Health Care Provider Recommendation, Human Papillomavirus Vaccination, and Race/ethnicity in the US National Immunization Survey

Overview

Journal Am J Public Health

Specialty Public Health

Date 2012 Jun 16

PMID 22698055

Citations 165

Authors

Kelly R Ylitalo

Hedwig Lee

Neil K Mehta

Affiliations

Soon will be listed here.

Abstract

Objectives: Human papillomavirus (HPV) is a common sexually transmitted infection in the United States, yet HPV vaccination rates remain relatively low. We examined racial/ethnic differences in the prevalence of health care provider recommendations for HPV vaccination and the association between recommendation and vaccination.

Methods: We used the 2009 National Immunization Survey-Teen, a nationally representative cross-section of female adolescents aged 13 to 17 years, to assess provider-verified HPV vaccination (≥ 1 dose) and participant-reported health care provider recommendation for the HPV vaccine.

Results: More than half (56.9%) of female adolescents received a recommendation for the HPV vaccine, and adolescents with a recommendation were almost 5 times as likely to receive a vaccine (odds ratio = 4.81; 95% confidence interval = 4.01, 5.77) as those without a recommendation. Racial/ethnic minorities were less likely to receive a recommendation, but the association between recommendation and vaccination appeared strong for all racial/ethnic groups.

Conclusions: Provider recommendations were strongly associated with HPV vaccination. Racial/ethnic minorities and non-Hispanic Whites were equally likely to obtain an HPV vaccine after receiving a recommendation. Vaccine education efforts should target health care providers to increase recommendations, particularly among racial/ethnic minority populations.

Citing Articles

A Qualitative Study of Attitudes Toward HPV Vaccine Recommendation in Otolaryngology Clinics.

Janio E, Walker C, Steere E, Seaman A, Askelson N, Pagedar N Laryngoscope Investig Otolaryngol. 2025; 10(1):e70085.

PMID: 39840027 PMC: 11748211. DOI: 10.1002/lio2.70085.

Socioeconomic/health-related factors associated with HPV vaccination initiation/completion among females of paediatric age: A systematic review with meta-analysis.

Okoli G, Grossman Moon A, Soos A, Neilson C, Kimmel Supron H, Etsell K Public Health Pract (Oxf). 2025; 9():100562.

PMID: 39802391 PMC: 11721234. DOI: 10.1016/j.puhip.2024.100562.

Behaviors and willingness to support HPV vaccination for women: a cross-sectional study of young adult men in China.

Wang W BMC Public Health. 2024; 24(1):3429.

PMID: 39695520 PMC: 11654176. DOI: 10.1186/s12889-024-20944-5.

Healthcare provider recommendations for COVID-19 vaccination: Prevalence, disparities, and correlates.

Willis D, Li J, Selig J, Moore R, Green A, Purvis R Patient Educ Couns. 2024; 130:108481.

PMID: 39504805 PMC: 11812527. DOI: 10.1016/j.pec.2024.108481.

Are HPV Vaccines Well Accepted among Parents of Adolescent Girls in China? Trends, Obstacles, and Practical Implications for Further Interventions: A Five-Year Follow-Up Study.

Huang Y, Ling J, Zhao X, Lv Q, Wang L, Wu Q Vaccines (Basel). 2024; 12(9).

PMID: 39340103 PMC: 11435455. DOI: 10.3390/vaccines12091073.

References

Bendik M, Mayo R, Parker V . Knowledge, perceptions, and motivations related to HPV vaccination among college women. J Cancer Educ. 2011; 26(3):459-64. DOI: 10.1007/s13187-011-0200-8. View

Bryer J . Human papillomavirus health policy. Policy Polit Nurs Pract. 2010; 11(1):23-8. DOI: 10.1177/1527154410370368. View

Guerry S, De Rosa C, Markowitz L, Walker S, Liddon N, Kerndt P . Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. Vaccine. 2011; 29(12):2235-41. DOI: 10.1016/j.vaccine.2011.01.052. View

Link B, Phelan J . Social conditions as fundamental causes of disease. J Health Soc Behav. 1995; Spec No:80-94. View

Schluterman N, Terplan M, Lydecker A, Tracy J . Human papillomavirus (HPV) vaccine uptake and completion at an urban hospital. Vaccine. 2011; 29(21):3767-72. DOI: 10.1016/j.vaccine.2011.03.032. View

Adams M, Jasani B, Fiander A . Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening. Vaccine. 2007; 25(16):3007-13. DOI: 10.1016/j.vaccine.2007.01.016. View

Rosenthal S, Rupp R, Zimet G, Meza H, Loza M, Short M . Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health. 2008; 43(3):239-45. DOI: 10.1016/j.jadohealth.2008.06.009. View

Taylor L, Hariri S, Sternberg M, Dunne E, Markowitz L . Human papillomavirus vaccine coverage in the United States, National Health and Nutrition Examination Survey, 2007-2008. Prev Med. 2010; 52(5):398-400. DOI: 10.1016/j.ypmed.2010.11.006. View

Lechuga J, Swain G, Weinhardt L . Perceived need of a parental decision aid for the HPV vaccine: content and format preferences. Health Promot Pract. 2011; 13(2):214-21. PMC: 4073688. DOI: 10.1177/1524839910388622. View

10.

Brewer N, Gottlieb S, Reiter P, McRee A, Liddon N, Markowitz L . Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis. 2010; 38(3):197-204. PMC: 3025264. DOI: 10.1097/OLQ.0b013e3181f12dbf. View

11.

Caskey R, Lindau S, Alexander G . Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adolesc Health. 2009; 45(5):453-62. DOI: 10.1016/j.jadohealth.2009.04.021. View

12.

Cardarelli R, Cardarelli K . Recommendations for primary care physicians to improve HPV vaccination rates during clinical encounters. Osteopath Med Prim Care. 2008; 2:10. PMC: 2577681. DOI: 10.1186/1750-4732-2-10. View

13.

Markowitz L, Dunne E, Saraiya M, Lawson H, Chesson H, Unger E . Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007; 56(RR-2):1-24. View

14.

Saha S, Komaromy M, Koepsell T, Bindman A . Patient-physician racial concordance and the perceived quality and use of health care. Arch Intern Med. 1999; 159(9):997-1004. DOI: 10.1001/archinte.159.9.997. View

15.

Dunne E, Unger E, Sternberg M, McQuillan G, Swan D, Patel S . Prevalence of HPV infection among females in the United States. JAMA. 2007; 297(8):813-9. DOI: 10.1001/jama.297.8.813. View

16.

Bednarczyk R, Birkhead G, Morse D, Doleyres H, McNutt L . Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race/ethnicity among female students at a New York State university, 2010. Vaccine. 2011; 29(17):3138-43. DOI: 10.1016/j.vaccine.2011.02.045. View

17.

Brewer N, Fazekas K . Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007; 45(2-3):107-14. DOI: 10.1016/j.ypmed.2007.05.013. View

18.

Rosenthal S, Weiss T, Zimet G, Ma L, Good M, Vichnin M . Predictors of HPV vaccine uptake among women aged 19-26: importance of a physician's recommendation. Vaccine. 2010; 29(5):890-5. DOI: 10.1016/j.vaccine.2009.12.063. View

19.

Litton A, Desmond R, Gilliland J, Huh W, Franklin F . Factors associated with intention to vaccinate a daughter against HPV: a statewide survey in Alabama. J Pediatr Adolesc Gynecol. 2011; 24(3):166-71. PMC: 3100399. DOI: 10.1016/j.jpag.2011.01.004. View

20.

Gerend M, Weibley E, Bland H . Parental response to human papillomavirus vaccine availability: uptake and intentions. J Adolesc Health. 2009; 45(5):528-31. DOI: 10.1016/j.jadohealth.2009.02.006. View